Pharmaceutical composition having reduced tendency for drug crystallization
CA 2434338 A1 · Owner: Huang, Tiehua · Inventors: Morozowich, Walter; Dalga, Robert J.; Forbes, James C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An orally deliverable pharmaceutical composition is provided comprising a drug of low water solubility, a solvent liquid that comprises at least one pharmaceutically acceptable solvent, and a turbidity-decreasing polymer wherein (a) a substantial portion, for example at least about 15 % by weight of the drug is in dissolved or solubilized form in the solvent liquid and (b) , the polymer is present in an amount sufficient to substantially inhibit crystallization and/or precipitation of the drug in simulated gastric fluid.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 15, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 15, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 15, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.